Related Experiment Video
Updated: Dec 26, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Common variants of fetal and maternal complement genes in preeclampsia: pregnancy specific complotype
Manu Banadakoppa1, Meena Balakrishnan2, Chandra Yallampalli3
1Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, Texas, USA. banadako@bcm.edu.
Insights
Preeclampsia (PE) risk may be linked to specific genetic variations in maternal and fetal complement genes, forming unique "complotypes." These genetic combinations appear more common in women with PE, suggesting a predisposition.
Area of Science:
- Immunogenetics
- Reproductive Medicine
- Perinatal Health
Background:
- Preeclampsia (PE) is a pregnancy-specific hypertensive disorder with potential life-threatening complications like eclampsia.
- Elevated systemic complement activation and placental deposition are observed in PE pregnancies.
- The role of genetic variations in complement pathways predisposing to PE requires further investigation.
Purpose of the Study:
- To investigate the hypothesis that combinations of common single nucleotide polymorphisms (SNPs) in maternal and fetal complement genes form pregnancy-specific complotypes that predispose women to PE.
- To identify common SNPs in maternal (factor H, C3) and fetal (CD46) complement genes and analyze their association with PE.
- To examine the relationship between identified genetic variants, placental complement deposition, and maternal alternative pathway activity.
Main Methods:
- Sequencing of maternal factor H (CFH) and C3 genes, and fetal CD46 gene to identify common SNPs.
- Genotyping analysis to determine the prevalence of identified SNPs and complotypes in PE patients and normotensive controls.
- Measurement of placental complement deposition and maternal alternative pathway 50 (AP50) activity.
- Assessment of placental CD46 expression and association with specific CD46 variants.
Main Results:
- Nine common SNPs were identified in the studied complement genes.
- Two fetal CD46 SNPs showed significantly higher minor allele frequencies in PE patients.
- Complotypes combining fetal CD46 variants with maternal CFH/C3 variants were more prevalent in PE pregnancies.
- Higher placental complement deposition and maternal AP50 values were observed in PE pregnancies.
- Specific CD46 variants correlated with reduced placental CD46 expression, and a CFH variant with increased maternal AP50.
Conclusions:
- Specific combinations of maternal and fetal complement gene variants (complotypes) are associated with an increased prevalence in preeclampsia.
- Fetal CD46 and maternal CFH/C3 gene variants may play a role in PE susceptibility.
- Genetic variations in complement genes influence placental complement deposition and maternal alternative pathway activity, contributing to PE pathophysiology.
Abstract:
Preeclampsia (PE) is a pregnancy specific hypertensive disorder. If untreated PE leads to life threatening condition, eclampsia. Systemic complement activation levels are increased during pregnancy compared to non-pregnant women of childbearing age. In PE, systemic complement levels are further increased, and higher complement deposition has been observed on placentas. We hypothesize that combinations of common SNPs in maternal and fetal complement genes constitute pregnancy specific complotypes and predispose women to PE. In this study, we sequenced two maternal (factor H and C3) and one fetal (CD46) complement genes and identified a total of 9 common SNPs. Minor allele frequencies of two fetal CD46 SNPs were significantly higher in PE. Further, complotypes consisting of fetal CD46 variants and maternal CFH/C3 variants were highly prevalent in PE patients compared to normotensive pregnancies. Placental complement deposition and maternal alternative pathway 50 (AP50) values were higher in PE pregnancies. Irrespective of disease status, two CD46 variants were associated with reduced placental CD46 expression and one CFH variant was associated with increased maternal AP50 values.
More Related Videos
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
07:51Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
Related Concept Videos
Complement System
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Teratogenicity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Selectins